MassMutual Private Wealth & Trust’s Xeris Biopharma Holdings XERS Stock Holding History

MassMutual Private Wealth & Trust’s Portfolio XERS Stock Details XERS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$7.03K	Sell	888 -246	-22%	-$1.57K	﹤0.01%	1553
2026 Q1	$6.58K	Buy	1,134 +456	+67%	+$3.02K	﹤0.01%	1551
2025 Q4	$5.32K	Sell	678 -216	-24%	-$1.7K	﹤0.01%	1653
2025 Q3	$7.28K	Buy	894 +340	+61%	+$2.26K	﹤0.01%	1526
2025 Q2	$2.59K	Buy	554 +134	+32%	+$614	﹤0.01%	1877
2025 Q1	$2.31K	Buy	+420	New	+$1.7K	﹤0.01%	1875
2022 Q4	–	Sell	-986	Closed	-$2K	–	1883
2022 Q3	$2K	Buy	+986	New	+$1.63K	﹤0.01%	1309

Other funds holding XERS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

MassMutual Private Wealth & Trust's XERS Position: Q2 2026 in Review

MassMutual Private Wealth & Trust reduced its Xeris Biopharma Holdings (XERS) stake by 22% in Q2 2026, selling an estimated $1.57K and leaving 888 shares worth $7.03K. The position accounts for ﹤0.01% of the portfolio, ranked #1553.

MassMutual Private Wealth & Trust first reported a position in XERS in Q3 2022 and has held it in 7 quarters since. The position peaked at $7.28K in Q3 2025. 240 funds tracked by Wall St. Rank hold XERS as of Q2 2026.

MassMutual Private Wealth & Trust held 888 shares of Xeris Biopharma Holdings worth $7.03K as of Q2 2026.
MassMutual Private Wealth & Trust sold 246 Xeris Biopharma Holdings shares in Q2 2026, an estimated $1.57K.
Xeris Biopharma Holdings made up ﹤0.01% of MassMutual Private Wealth & Trust's portfolio in Q2 2026, its #1553 holding.
MassMutual Private Wealth & Trust first reported a position in Xeris Biopharma Holdings in Q3 2022 and has held it in 7 quarters since.
MassMutual Private Wealth & Trust's Xeris Biopharma Holdings position peaked at $7.28K in Q3 2025.
240 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q2 2026.

Based on MassMutual Private Wealth & Trust's 13F filing for Q2 2026, filed 2 Jul 2026.